This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: D4 Labs, LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Michael Bowe: Innovator in Vaccine Development
Introduction
Michael Bowe is an accomplished inventor based in Marina, CA (US). He has made significant contributions to the field of vaccine development, particularly in the context of SARS-CoV-2. His innovative work focuses on creating effective adjuvanted vaccines that can enhance immune responses.
Latest Patents
Michael Bowe holds a patent for "Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use." This patent discloses adjuvanted protein vaccines that comprise a modified S1 Spike protein sequence from the SARS-CoV-2 variant C.1.2, encapsulated within a non-phospholipid liposome. The vaccines are designed for subcutaneous administration, providing a novel approach to immunization against this variant.
Career Highlights
Throughout his career, Michael has demonstrated a commitment to advancing medical science through innovative solutions. His work at D4 Labs, LLC has positioned him as a key player in the development of cutting-edge vaccine technologies. His patent reflects his dedication to addressing public health challenges posed by emerging viral variants.
Collaborations
Michael collaborates with talented individuals in his field, including Emily Wright and David Craig Wright. These partnerships enhance the research and development efforts at D4 Labs, LLC, fostering an environment of innovation and creativity.
Conclusion
Michael Bowe's contributions to vaccine development exemplify the spirit of innovation in the medical field. His patented work on adjuvanted vaccines represents a significant advancement in the fight against SARS-CoV-2. Through his efforts, he continues to make a positive impact on public health.